Home/Filings/4/0000950170-25-106531
4//SEC Filing

ARMEN GARO H 4

Accession 0000950170-25-106531

CIK 0001098972other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 4:05 PM ET

Size

7.2 KB

Accession

0000950170-25-106531

Insider Transaction Report

Form 4
Period: 2025-08-08
ARMEN GARO H
DirectorSee Remarks
Transactions
  • Award

    Common Stock

    2025-08-08$4.80/sh+3,407$16,354267,311 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    31,298
  • Common Stock

    (indirect: See Footnote)
    28,950
Footnotes (4)
  • [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending August 8, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
  • [F2]$4.80 is the closing price of our Common Stock on August 8, 2025, the last trading day for the payroll date for the pay period ending August 8, 2025.
  • [F3]Shares are held in Dr. Armen's IRA accounts.
  • [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Documents

1 file

Issuer

AGENUS INC

CIK 0001098972

Entity typeother

Related Parties

1
  • filerCIK 0000935679

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:05 PM ET
Size
7.2 KB